bilaterals.org logo
bilaterals.org logo

intellectual property

Trump’s USTR nominee pledges tough enforcement of U.S. trade laws
15-Mar-2017 Reuters
Lighthizer pledged to fight for strong protections for intellectual property rights and for digital trade access.
India should not let Europe undermine its new BIT and TRIPs flexibilities for medicines
27-Feb-2017 Sunday Guardian Live
There is no principled basis for EU’s demand of extending patent protection beyond the period of 20 years.
Law professors address RCEP negotiators on copyright
26-Feb-2017 Electronic Frontier Foundation
The recent death of the TPP has thrust RCEP further into the spotlight, and raised the stakes both for its sixteen prospective parties, and for lobbyists with designs to stamp their own mark on the text’s intellectual property and e-commerce chapters.
MSF calls on Japan and South Korea to drop the harmful RCEP measures
26-Feb-2017 MSF
The intellectual property provisions initiated by Japan and South Korea go far beyond the requirements needed under international trade rules.
A ’new’ recipe for trade
24-Feb-2017 Economic & Political Weekly
With other mega regional trade agreements like the Trans–Pacific Partnership in uncertainty, trade treaties like the Regional Comprehensive Economic Partnership will acquire greater significance beyond their original ASEAN-centred grouping. The RCEP needs to be tracked for its implications for both the global trading system and the livelihoods of people.
EU-Indonesia FTA - draft intellectual property chapter (December 2016)
14-Feb-2017 European Commission
As published by the European Commission
TPP is dead, but its legacy lives on
10-Feb-2017 The Hindu
The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements
A case for trade enforcement: Colombia and intellectual property
2-Feb-2017 IP Watch
President Trump and members of his administration have talked about the need to be tougher on trade enforcement
Why President Trump is wrong about Trans-Pacific Partnership Agreement
31-Jan-2017 Patent Docs
The TPP was generally favorable to American interests because its provisions favored American innovators, specifically biotechnology and pharmaceutical companies.
Walking the fine line between IP and public health
20-Jan-2017 The Hindu
The rise of a protectionist US under President Donald Trump, may have long-term implications on India’s public health objectives
Will the RCEP morph into another TPP?
12-Jan-2017 Third World Resurgence
In highlighting that the drafts of many of its key chapters are substantially similar to those of the TPP, Sanya Reid Smith warns that the RCEP may end up as a replica of the former.
Implementation of Indo-Japan free trade agreement needs to be expedited: Nirmala Sitharaman
10-Jan-2017 Financial Express
The pace of implementation of Indo-Japan free trade agreement needs to be further enhanced in order to exploit the huge potential of the pact, Commerce and Industry Minister Nirmala Sitharaman said.
Lessons to learn from the demise of the TPP
9-Jan-2017 The Wire
With the imminent demise of the Tran-Pacific Partnership Agreement almost certain, there are many lessons to be learnt from the fraudulent free trade deal.
Investigation: As Colombia pushes for cancer drug price-cut and considers compulsory licensing, Novartis responds with quiet filing of an investment treaty notice
2-Jan-2017 IA Reporter
Novartis lodged a formal notice of dispute under the Switzerland-Colombia BIT.
Trade deals can have adverse impact on access to generic medicines
30-Dec-2016 Governance Now
Interview with Dr Peter Ghys, interim director, strategic information and evaluation, UNAIDS
Report shows trade agreements have boosted medicine and copyright monopolies
21-Dec-2016 AFTINET
Global pharmaceutical companies have successfully lobbied for longer monopolies in trade agreements which have delayed the availability of cheaper medicines, resulting in higher prices.
Don’t cry over dead trade agreements
14-Dec-2016 Live Mint
If we can manage our own economies well, new trade pacts will become largely redundant.
The Regional Comprehensive Economic Partnership, intellectual property protection and access to medicines
14-Dec-2016 SSRN
This paper identifies TRIPS-Plus provisions in leaked RCEP negotiating texts and examines their implications for low and middle-income countries.
Longer monopolies and single legal proceedings vs. generics - the gift of CETA to Canadian drug patentees
13-Dec-2016 Lexology
Canadian pharmaceutical patent owners can expect two substantive changes in the next year following implementation of the Canada–European Union trade agreement
Regional trade meet should not pave way for monopoly in drugs: Doctors without Borders
12-Dec-2016 The Times of India
Doctors Without Borders/Medecins Sans Frontieres (MSF) and other health groups have reiterated concerns about harmful intellectual property provisions in the RCEP